Related Experiment Videos
Hyperalgesic priming in the rat demonstrates marked sexual dimorphism
Elizabeth K Joseph1, Carlos A Parada, Jon D Levine
1Department of Medicine, UCSF-NIH Pain Center, University of California, San Francisco, CA 94143-0440, USA. aley@itsa.ucsf.edu
Pain
|September 23, 2003
Summary
Estrogen suppresses inflammatory hyperalgesic priming in female rats, a phenomenon involving protein kinase C epsilon (PKCε). This effect was reversed by estrogen replacement in ovariectomized rats, highlighting estrogen
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Hyperalgesic priming, a prolonged pain hypersensitivity, is observed in male rats following carrageenan (CAR) or protein kinase C epsilon (PKCε) agonist exposure.
- Sexually dimorphic differences in chronic inflammatory conditions suggest potential gender-specific mechanisms in pain sensitization.
Purpose of the Study:
- To investigate the hypothesis that hyperalgesic priming is sexually dimorphic.
- To determine the role of estrogen in modulating inflammation-induced hyperalgesic priming.
Main Methods:
- Carrageenan (CAR)-induced inflammation or selective protein kinase C epsilon (PKCε) agonist (psiRACK) administration in male and female rats.
- Ovariectomy and estrogen replacement therapy in female rats.
- Gonadectomy and estrogen implantation in male rats.
- Assessment of prostaglandin E(2) (PGE(2))-induced hyperalgesia.
Main Results:
- Hyperalgesic priming was observed only in male rats after CAR or psiRACK administration.
- Ovariectomized female rats exhibited priming effects similar to males, which were reversed by estrogen.
- Estrogen replacement in ovariectomized females and estrogen implantation in males suppressed hyperalgesic priming.
- Male gonadectomy did not affect priming, suggesting estrogen's suppressive role.
Conclusions:
- Estrogen suppresses the development of inflammation-induced hyperalgesic priming.
- The regulatory mechanism of estrogen appears to act at or downstream of PKCε activation.
- These findings reveal a significant sex difference in pain priming mechanisms, modulated by estrogen.